Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD 0200390 Dose Ranging Trial: A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

NCT00569972 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00569972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00569972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD 0200390 Dose Ranging Trial: A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
January 31, 2009
Enrollment
682 (actual)
Sites
84

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia